SCHEMBL8865619

SCHEMBL8865619

COc1ccc2c(c1)CC=C2c1c[nH]cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.45
ELANE P08246 1/20 0.38
MPO P05164 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
METAP1 P53582 1/20 0.35
ADORA1 P30542 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
MMP12 P39900 1/20 0.34
CYP19A1 P11511 3/20 0.34
CYP17A1 P05093 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
SRC P12931 1/20 0.33
CYP11B2 P19099 1/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29222704 0.75 ADRA2A (0.40) CYP3A4KDM4EALDH1A1MAPTCYP1A2
SCHEMBL30543399 0.75 ADRA2A (0.40) CYP3A4KDM4EALDH1A1MAPTCYP1A2
SCHEMBL7608467 0.75 HTR6 (0.31)
Hydrochloric Acid SCHEMBL7608217 0.74 HTR6 (0.30)
SCHEMBL8865283 0.72 KDM4E (0.38) KDM4EALDH1A1
SCHEMBL31414398 0.71 CYP3A4 (0.58) CYP3A4ELANEMPOMAPTMETAP1
SCHEMBL17607328 0.70 ALDH1A1 (0.42) CYP3A4KDM4EALDH1A1MAPTHTT
SCHEMBL31546885 0.68 NPC1 (0.53) CYP3A4KDM4EALDH1A1MAPTCYP1A2
SCHEMBL2202915 0.68 NPC1 (0.47) KDM4EALDH1A1MAPTDYRK1A
SCHEMBL29248715 0.68 MPO (0.47) CYP3A4MPOKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658938-A HYPOTENSIVE AGENT, ANTIISCHMIC AGENTS U C B S.A. (BE) 1997-08-19 US disclosed
EP-0717037-A1 Substituted 1H-imidazoles having alpha 2-agonistic and alpha 1-antagonistic activity U C B, S.A. (BE) 1996-06-19 EP disclosed